Regeneron Pharmaceuticals Inc.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$4,860
Revenue Growth (%)18.44%
Net Income (US$ Millions)$896
Earnings Per Share (US$)$7.70
EPS Growth Rate (%)39.49%
Profit Margin18.42%
Total Equity (US$ Millions)$4,449
Return on Equity (%)24.50%
Long Term Debt (US$ Millions)$352
Debt To Equity Ratio (%)0.08%
Total Assets (US$ Millions)$6,973
Current Assets (US$ Millions)$3,180
Current Liabilities (US$ Millions)$1,241
Cost of Goods Sold (US$ Millions)$300
Inventory Turnover0.94